Mushroom Polysaccharides: Regulators of Insulin Signaling and Adiponectin
When a Fat Cell Releases a Hormone
— FOCUS —
Adipose tissue was long regarded as a passive storage depot. The contemporary picture is different: fat cells secrete a class of hormones termed adipokines. The most renowned among them — and, paradoxically, the one that declines as obesity rises — is adiponectin. Elevated adiponectin keeps the liver and muscle more insulin-sensitive.
This entry examines the molecular foundation of the insulin signaling pathway and how functional mushroom polysaccharides interact with adiponectin and insulin sensitivity in the scientific literature.
Insulin Signaling Pathway: From Receptor to Glucose Transporter
Insulin binds its receptor. The receptor’s tyrosine kinase activity is initiated, and IRS‑1/2 becomes phosphorylated. This step activates PI3K, which engages Akt protein kinase. Ultimately, GLUT4 translocates to the plasma membrane and glucose enters the cell.
Insulin resistance generally reflects a signaling attenuation at some point in this cascade. Serine phosphorylation of IRS‑1 (instead of tyrosine) is one of the classic mechanisms of that attenuation (Saltiel & Kahn, 2001; PMID: 11742412).
Adiponectin: The Beneficial Hormone of Adipose Tissue
Adiponectin is produced in fat cells. It acts through AdipoR1 and AdipoR2 receptors. In the liver it reduces gluconeogenesis; in muscle it enhances fatty acid oxidation. The net effect is improved insulin sensitivity and lower hepatic triglyceride content.
A key downstream target of adiponectin receptor signaling is AMPK, which means adiponectin transmits a large share of its metabolic effects through AMPK (Yamauchi et al., 2002; PMID: 12068290).
The Obesity Paradox
As fat mass expands, adiponectin declines. This appears counter‑intuitive at first glance but is internally consistent: when adipocytes undergo hypertrophy, adiponectin transcription is suppressed and inflammatory cytokine release rises. That combination accelerates insulin resistance.
For this reason, the adiponectin level is regarded as a metabolic‑health indicator independent of body mass index (Kadowaki & Yamauchi, 2005; PMID: 15897298).
Mushroom Polysaccharides and the Insulin/Adiponectin Literature
Maitake D‑fraction has been reported to improve insulin sensitivity in animal models; the hypothesized mechanism operates through an increase in adiponectin expression in adipose tissue (Hong et al., 2007; PMID: 17604577).
Reishi polysaccharides have been observed in vitro to improve hepatic IRS‑1 phosphorylation and facilitate GLUT4 translocation (Xiao et al., 2012; PMID: 22634862).
Cordyceps polysaccharides possess animal data showing a favorable trend on glucose tolerance and adiponectin levels; however, human intervention studies remain limited (Choi et al., 2014; PMID: 24631605).
The Gut Microbiota Bridge
Mushroom β‑glucans are fermented in the large intestine, producing short‑chain fatty acids (SCFAs). SCFAs — especially butyrate and propionate — are associated with positive effects on peripheral insulin sensitivity. This suggests that a microbiota‑mediated component, rather than a direct one, partly explains the influence of mushrooms on adipose tissue and metabolic health (Canfora et al., 2015; PMID: 26303955).
Limitations
The evidence base for mushroom polysaccharides on the insulin signaling pathway and adiponectin consists largely of animal models and in vitro designs. Human intervention studies are scarce and heterogeneous. The findings should be read as a set of mechanisms worth investigating, not as a therapeutic approach.
Related Reading
- Mushrooms and Diabetes — An overview of glucose metabolism.
- Mushrooms and Cholesterol — The connection with lipid metabolism.
- D‑Fraction — The Maitake polysaccharide fraction.
This content is for informational purposes and does not constitute medical advice. Consult your physician before making any health decision. Functional mushrooms are not drugs and cannot be used to treat diseases.
Version: 1.0 | Last updated: 28 April 2026 | Sources reviewed: 12+ | Method: Editorial Policy | References: Bibliography
